{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:49:55Z","timestamp":1793508595673,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F32 CA257210"],"award-info":[{"award-number":["F32 CA257210"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The unintended neurologic sequelae of chemotherapy contribute to significant patient morbidity. Chemotherapy-related cognitive impairment (CRCI) is observed in up to 80% of cancer patients treated with chemotherapy and involves multiple cognitive domains including executive functioning. The pathophysiology underlying CRCI and the neurotoxicity of chemotherapy is incompletely understood, but oxidative stress and DNA damage are highly plausible mechanisms based on preclinical data. Unfortunately, validating pathways relevant to CRCI in humans is limited by an absence of relevant neuropathologic studies of patient brain tissue. In the present study, we stained sections of frontal lobe autopsy tissue from cancer patients treated with chemotherapy (n\u2009=\u200915), cancer patients not treated with chemotherapy (n\u2009=\u200910), and patients without history of cancer (n\u2009=\u200910) for markers of oxidative stress (nitrotyrosine, 4-hydroxynonenal) and DNA damage (pH2AX, pATM). Cancer patients treated with chemotherapy had increased staining for markers of oxidative stress and DNA damage in frontal lobe cortical neurons compared to controls. We detected no statistically significant difference in oxidative stress and DNA damage by the duration between last administration of chemotherapy and death. The study highlights the potential relevance of oxidative stress and DNA damage in the pathophysiology of CRCI and the neurotoxicity of chemotherapy.<\/jats:p>","DOI":"10.1093\/jnen\/nlab074","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T19:10:31Z","timestamp":1628363431000},"page":"705-712","source":"Crossref","is-referenced-by-count":30,"title":["Elevated Oxidative Stress and DNA Damage in Cortical Neurons of Chemotherapy Patients"],"prefix":"10.1093","volume":"80","author":[{"given":"Matthew","family":"Torre","sequence":"first","affiliation":[{"name":"From the Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwitia","family":"Dey","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared K","family":"Woods","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel B","family":"Feany","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"2024032523410594100_nlab074-B1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2024032523410594100_nlab074-B2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-009-0071-x","article-title":"Neurologic complications of cancer and its treatment","volume":"12","author":"Giglio","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"2024032523410594100_nlab074-B3","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2012.43.0116","article-title":"Cancer- and cancer treatment-associated cognitive change: An update on the state of the science","volume":"30","author":"Ahles","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024032523410594100_nlab074-B4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","article-title":"Chemotherapy-related cognitive dysfunction","volume":"12","author":"Wefel","year":"2012","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2024032523410594100_nlab074-B5","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10549-011-1888-1","article-title":"Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy","volume":"132","author":"Koppelmans","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"2024032523410594100_nlab074-B6","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","article-title":"Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: A replication and extension study","volume":"30 Suppl","author":"McDonald","year":"2013","journal-title":"Brain Behav Immun"},{"key":"2024032523410594100_nlab074-B7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1200\/JCO.2011.36.8571","article-title":"Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning","volume":"30","author":"Deprez","year":"2012","journal-title":"JCO"},{"key":"2024032523410594100_nlab074-B8","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1158\/1078-0432.CCR-09-1227","article-title":"Regional brain activation during verbal declarative memory in metastatic breast cancer","volume":"15","author":"Kesler","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2024032523410594100_nlab074-B9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdf241","article-title":"Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients","volume":"13","author":"Schagen","year":"2002","journal-title":"Ann Oncol"},{"key":"2024032523410594100_nlab074-B10","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1002\/cncr.20272","article-title":"The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial","volume":"100","author":"Wefel","year":"2004","journal-title":"Cancer"},{"key":"2024032523410594100_nlab074-B11","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1002\/cncr.25098","article-title":"Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer","volume":"116","author":"Wefel","year":"2010","journal-title":"Cancer"},{"key":"2024032523410594100_nlab074-B12","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2011.37.0189","article-title":"Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy","volume":"30","author":"Koppelmans","year":"2012","journal-title":"JCO"},{"key":"2024032523410594100_nlab074-B13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bandc.2005.05.001","article-title":"The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature","volume":"59","author":"Falleti","year":"2005","journal-title":"Brain Cogn"},{"key":"2024032523410594100_nlab074-B14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10926-017-9736-8","article-title":"Functional impairments and work-related outcomes in breast cancer survivors: A systematic review","volume":"28","author":"Bijker","year":"2018","journal-title":"J Occup Rehabil"},{"key":"2024032523410594100_nlab074-B15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejon.2012.06.002","article-title":"Impact of perceived cognitive impairment in breast cancer survivors","volume":"17","author":"Von Ah","year":"2013","journal-title":"Eur J Oncol Nurs"},{"key":"2024032523410594100_nlab074-B16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","article-title":"Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review","volume":"38","author":"Hutchinson","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"2024032523410594100_nlab074-B17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pbc.22128","article-title":"Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia","volume":"53","author":"Caron","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"2024032523410594100_nlab074-B18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.freeradbiomed.2016.11.046","article-title":"Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats","volume":"102","author":"Lomeli","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"2024032523410594100_nlab074-B19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/10715760500143478","article-title":"Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain","volume":"39","author":"Joshi","year":"2005","journal-title":"Free Radic Res"},{"key":"2024032523410594100_nlab074-B20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2010.01.021","article-title":"Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: Implications for oxidative stress-mediated chemobrain","volume":"166","author":"Joshi","year":"2010","journal-title":"Neuroscience"},{"key":"2024032523410594100_nlab074-B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.12.029","article-title":"The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (\u201cchemobrain\u201d) involving TNF-alpha","volume":"134","author":"Ren","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"2024032523410594100_nlab074-B22","doi-asserted-by":"crossref","first-page":"30324","DOI":"10.18632\/oncotarget.25718","article-title":"Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: Protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d)","volume":"9","author":"Keeney","year":"2018","journal-title":"Oncotarget"},{"key":"2024032523410594100_nlab074-B23","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","article-title":"Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus","volume":"56","author":"Bagnall-Moreau","year":"2019","journal-title":"Mol Neurobiol"},{"key":"2024032523410594100_nlab074-B24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.lfs.2013.03.013","article-title":"Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment","volume":"93","author":"Krynetskiy","year":"2013","journal-title":"Life Sci"},{"key":"2024032523410594100_nlab074-B25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10549-012-2385-x","article-title":"Alterations in brain structure and function in breast cancer survivors: Effect of post-chemotherapy interval and relation to oxidative DNA damage","volume":"137","author":"Conroy","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2024032523410594100_nlab074-B26","doi-asserted-by":"crossref","first-page":"25705","DOI":"10.1038\/srep25705","article-title":"Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons","volume":"6","author":"Manchon","year":"2016","journal-title":"Sci Rep"},{"key":"2024032523410594100_nlab074-B27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cell.2018.10.049","article-title":"Methotrexate chemotherapy induces persistent tri-glial dysregulation that underlies chemotherapy-related cognitive impairment","volume":"176","author":"Gibson","year":"2019","journal-title":"Cell"},{"key":"2024032523410594100_nlab074-B28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/0008-5472.CAN-14-2237","article-title":"Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction","volume":"75","author":"Acharya","year":"2015","journal-title":"Cancer Res"},{"key":"2024032523410594100_nlab074-B29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuron.2019.04.032","article-title":"Loss of adaptive myelination contributes to methotrexate chemotherapy-related cognitive impairment","volume":"103","author":"Geraghty","year":"2019","journal-title":"Neuron"},{"key":"2024032523410594100_nlab074-B30","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.bbi.2012.05.017","article-title":"Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors","volume":"30","author":"Kesler","year":"2013","journal-title":"Brain Behav Immun"},{"key":"2024032523410594100_nlab074-B31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/jbiol50","article-title":"CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo","volume":"5","author":"Dietrich","year":"2006","journal-title":"J Biol"},{"key":"2024032523410594100_nlab074-B32","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-11-2000","article-title":"Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy","volume":"18","author":"Christie","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2024032523410594100_nlab074-B33","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1111\/ejn.12007","article-title":"Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain","volume":"36","author":"Nokia","year":"2012","journal-title":"Eur J Neurosci"},{"key":"2024032523410594100_nlab074-B34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuroscience.2017.10.048","article-title":"Neurobiological mechanisms of chemotherapy-induced cognitive impairment in a transgenic model of breast cancer","volume":"369","author":"Winocur","year":"2018","journal-title":"Neuroscience"},{"key":"2024032523410594100_nlab074-B35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/CCO.0000000000000578","article-title":"Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment","volume":"31","author":"Gibson","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"2024032523410594100_nlab074-B36","doi-asserted-by":"crossref","first-page":"e12075","DOI":"10.15252\/emmm.202012075","article-title":"Cellular mechanisms and treatments for chemobrain: Insight from aging and neurodegenerative diseases","volume":"12","author":"Nguyen","year":"2020","journal-title":"EMBO Mol Me"},{"key":"2024032523410594100_nlab074-B37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-017-4376-4","article-title":"Executive functioning impairment in women treated with chemotherapy for breast cancer: A systematic review","volume":"166","author":"Yao","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"2024032523410594100_nlab074-B38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","article-title":"A meta-analysis of the effects of chemotherapy on cognition in patients with cancer","volume":"39","author":"Hodgson","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"2024032523410594100_nlab074-B39","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.21469","article-title":"A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function","volume":"104","author":"Jansen","year":"2005","journal-title":"Cancer"},{"key":"2024032523410594100_nlab074-B40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neubiorev.2018.05.019","article-title":"Longitudinal assessment of chemotherapy-induced changes in brain and cognitive functioning: A systematic review","volume":"92","author":"Li","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"2024032523410594100_nlab074-B41","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2011.245","article-title":"Prefrontal cortex and executive function impairments in primary breast cancer","volume":"68","author":"Kesler","year":"2011","journal-title":"Arch Neurol"},{"key":"2024032523410594100_nlab074-B42","doi-asserted-by":"crossref","first-page":"e0151615","DOI":"10.1371\/journal.pone.0151615","article-title":"Individual case analysis of postmortem interval time on brain tissue preservation","volume":"11","author":"Blair","year":"2016","journal-title":"PLoS One"},{"key":"2024032523410594100_nlab074-B43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-2522-3_7","article-title":"Detecting reactive oxygen species by immunohistochemistry","volume":"1292","author":"Liou","year":"2015","journal-title":"Methods Mol Biol"},{"key":"2024032523410594100_nlab074-B44","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J Biol Chem"},{"key":"2024032523410594100_nlab074-B45","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1038\/sj.onc.1210872","article-title":"Activation and regulation of ATM kinase activity in response to DNA double-strand breaks","volume":"26","author":"Lee","year":"2007","journal-title":"Oncogene"},{"key":"2024032523410594100_nlab074-B46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2006.02.013","article-title":"Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity","volume":"23","author":"Tangpong","year":"2006","journal-title":"Neurobiol Dis"},{"key":"2024032523410594100_nlab074-B47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000097202","article-title":"Passage of cytokines across the blood-brain barrier","volume":"2","author":"Banks","year":"1995","journal-title":"Neuroimmunomodulation"},{"key":"2024032523410594100_nlab074-B48","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1073\/pnas.0806682105","article-title":"Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation","volume":"105","author":"Riazi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032523410594100_nlab074-B49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.path.2020.01.004","article-title":"Iatrogenic neuropathology of systemic therapies","volume":"13","author":"Torre","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"2024032523410594100_nlab074-B50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/mi.7.3.6","article-title":"Collateral damage in cancer chemotherapy: Oxidative stress in nontargeted tissues","volume":"7","author":"Chen","year":"2007","journal-title":"Mol Interv"},{"key":"2024032523410594100_nlab074-B51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: Impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr Cancer Ther"},{"key":"2024032523410594100_nlab074-B52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nature02661","article-title":"Gene regulation and DNA damage in the ageing human brain","volume":"429","author":"Lu","year":"2004","journal-title":"Nature"},{"key":"2024032523410594100_nlab074-B53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fnmol.2019.00132","article-title":"Neuronal cells rearrangement during aging and neurodegenerative disease: Metabolism, oxidative stress and organelles dynamic","volume":"12","author":"Castelli","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"2024032523410594100_nlab074-B54","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.2174\/0929867325666180629123817","article-title":"Cancer-associated cachexia, reactive oxygen species and nutrition therapy","volume":"26","author":"Bjorklund","year":"2019","journal-title":"Curr Med Chem"},{"key":"2024032523410594100_nlab074-B55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1017\/S1355617713001215","article-title":"Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy","volume":"20","author":"Collins","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"key":"2024032523410594100_nlab074-B56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/cncr.22368","article-title":"Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy","volume":"109","author":"Inagaki","year":"2007","journal-title":"Cancer"},{"key":"2024032523410594100_nlab074-B57","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11682-013-9244-1","article-title":"Chemotherapy altered brain functional connectivity in women with breast cancer: A pilot study","volume":"7","author":"Dumas","year":"2013","journal-title":"Brain Imaging Behav"},{"key":"2024032523410594100_nlab074-B58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1099800415577633","article-title":"Moderating effects of genetic polymorphisms on improvements in cognitive impairment in breast cancer survivors participating in a 6-week mindfulness-based stress reduction program","volume":"17","author":"Lengacher","year":"2015","journal-title":"Biol Res Nurs"},{"key":"2024032523410594100_nlab074-B59","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.19.01085","article-title":"Clinical and genetic risk prediction of cognitive impairment after blood or marrow transplantation for hematologic malignancy","volume":"38","author":"Sharafeldin","year":"2020","journal-title":"J Clin Oncol"},{"key":"2024032523410594100_nlab074-B60","doi-asserted-by":"crossref","first-page":"1485283","DOI":"10.1155\/2017\/1485283","article-title":"Reactive oxygen species-mediated mechanisms of action of targeted cancer therapy","volume":"2017","author":"Teppo","year":"2017","journal-title":"Oxid Med Cell Longev"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/7\/705\/41696365\/nlab074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/7\/705\/41696365\/nlab074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:11:02Z","timestamp":1711411862000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/80\/7\/705\/6345385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":60,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,8,10]]},"published-print":{"date-parts":[[2021,8,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlab074","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,7,1]]}}}